Table 3.
Age- and Gender-Specific Prevalence of Open-angle Glaucoma
Age, y | Female
|
Male
|
Both
|
||||
---|---|---|---|---|---|---|---|
No./No. | Prevalence/100, % (95% CI)
|
No./No. | Prevalence/100, % (95% CI)
|
Prevalence/100, % (95% CI)
|
|||
Observed | Adjusteda | Observed | Adjusteda | Adjusteda,b | |||
40–49 | 48/1663 | 2.9 (2.1–3.8) | 3.1 (2.3–4.0) | 40/943 | 4.2 (3.0–5.7) | 4.6 (3.2–5.9) | 3.7 (3.0–4.4) |
50–59 | 45/939 | 4.8 (3.5–6.4) | 5.4 (4.0–6.8) | 45/648 | 6.9 (5.1–9.2) | 7.7 (5.7–9.7) | 6.3 (5.2–7.5) |
60–69 | 40/459 | 8.7 (6.3–11.7) | 10.0 (7.4–12.7) | 53/405 | 13.1 (10.0–16.8) | 14.6 (11.2–17.9) | 12.2 (10.1–14.3) |
70–79 | 21/210 | 10.0 (6.3–14.9) | 11.5 (7.3–15.7) | 30/186 | 16.1 (11.2–22.2) | 17.8 (12.4–23.2) | 14.6 (11.2–17.9) |
≥ 80 | 12/108 | 11.1 (5.9–18.6) | 12.3 (6.3–18.4) | 8/42 | 19.0 (8.6–34.1) | 20.1 (8.1–32.1) | 14.6 (9.0–20.1) |
Total | 166/3379 | 4.9 (4.2–5.7) | 5.5 (4.8–6.3) | 176/2224 | 7.9 (6.8–9.1) | 8.7 (7.6–9.8) | 6.8 (6.2–7.4) |
Abbreviation: No./No., number with glaucoma/number who received field examination.
Adjusted prevalence was adjusted for nonparticipation in the clinic examination.
Observed prevalence for both males and females is displayed in Table 4.